Skip to main content

PREGABALIN

NDC 71209-032 · Cadila Pharmaceuticals Limited

Generic namePREGABALIN

Dosage formCAPSULE

RouteORAL

Active ingredient(s)PREGABALIN

Strength25 mg/1

DEA scheduleCV

Marketing categoryANDA

Packages

71209-032-04 — 90 CAPSULE in 1 BOTTLE (71209-032-04)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

71205-733 — Pregabalin, 71205-816 — Pregabalin, 71205-869 — Pregabalin, 71205-870 — Pregabalin, 71205-871 — Pregabalin, 71205-872 — Pregabalin, 71205-873 — Pregabalin, 71205-874 — Pregabalin, 71205-875 — Pregabalin, 71205-876 — Pregabalin, 71209-033 — PREGABALIN, 71209-034 — PREGABALIN, 71209-035 — PREGABALIN, 71209-036 — PREGABALIN, 71209-037 — PREGABALIN, 71209-038 — PREGABALIN, 71209-039 — PREGABALIN, 71335-1300 — PREGABALIN, 71335-1459 — PREGABALIN, 71335-1475 — PREGABALIN, +519 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels